These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36890643)

  • 1. Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents.
    Bae S; Ahn JB; Joseph C; Whisler R; Schnitzler MA; Lentine KL; Kadosh BS; Segev DL; McAdams-DeMarco MA
    J Am Soc Nephrol; 2023 Jun; 34(6):1069-1077. PubMed ID: 36890643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients.
    Bae S; Ahn JB; Joseph C; Whisler R; Schnitzler MA; Lentine KL; Kadosh BS; Segev DL; McAdams-DeMarco MA
    Clin J Am Soc Nephrol; 2023 May; 18(5):626-633. PubMed ID: 36800538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice patterns in arteriovenous fistula ligation among kidney transplant recipients in the United States Renal Data Systems.
    Hicks CW; Bae S; Pozo ME; DiBrito SR; Abularrage CJ; Segev DL; Garonzik-Wang J; Reifsnyder T
    J Vasc Surg; 2019 Sep; 70(3):842-852.e1. PubMed ID: 30853386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
    Younas N; Wu CM; Shapiro R; McCauley J; Johnston J; Tan H; Basu A; Schaefer H; Smetanka C; Winkelmayer WC; Unruh M
    BMC Nephrol; 2010 Apr; 11():5. PubMed ID: 20359353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractures and Subsequent Graft Loss and Mortality among Older Kidney Transplant Recipients.
    Salter ML; Liu X; Bae S; Chu NM; Miller Dunham A; Humbyrd C; Segev DL; McAdams-DeMarco MA
    J Am Geriatr Soc; 2019 Aug; 67(8):1680-1688. PubMed ID: 31059126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD005019. PubMed ID: 19370615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.
    Badve SV; Pascoe EM; Burke M; Clayton PA; Campbell SB; Hawley CM; Lim WH; McDonald SP; Wong G; Johnson DW
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1845-1855. PubMed ID: 27445164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Maintenance Immunosuppressive Regimens and COVID-19 Mortality in Kidney Transplant Recipients.
    Gérard AO; Barbosa S; Anglicheau D; Couzi L; Hazzan M; Thaunat O; Blancho G; Caillard S; Sicard A;
    Transplantation; 2022 Oct; 106(10):2063-2067. PubMed ID: 35883236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
    Yanik EL; Chinnakotla S; Gustafson SK; Snyder JJ; Israni AK; Segev DL; Engels EA
    Liver Transpl; 2016 May; 22(5):627-34. PubMed ID: 26784951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
    Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
    Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant.
    Wijesinha M; Hirshon JM; Terrin M; Magder L; Brown C; Stafford K; Iacono A
    JAMA Netw Open; 2019 Aug; 2(8):e1910297. PubMed ID: 31461151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and hip fractures in U.S. kidney transplant recipients.
    Vangala C; Lenihan CR; Montez-Rath ME; Nair SS; Navaneethan SD; Ramanathan V; Winkelmayer WC
    BMC Nephrol; 2017 May; 18(1):145. PubMed ID: 28460645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy and the incidence of atherosclerotic cardiovascular events after kidney transplantation.
    Nazoiri C; Liabeuf S; Brazier F; Nowak A; Bennis Y; Laville SM; Bodeau S; Gras-Champel V; Masmoudi K; Choukroun G; Batteux B
    Nephrol Dial Transplant; 2024 Apr; 39(5):818-829. PubMed ID: 37791395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.
    Opelz G; Unterrainer C; Süsal C; Döhler B
    Nephrol Dial Transplant; 2016 Aug; 31(8):1360-7. PubMed ID: 27190384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive Role of mTOR Inhibitor in Post-Kidney Transplant Urothelial Carcinoma.
    Chang YL; Lee HC; Luo HL; Chen YT; Chiang PH; Cheng YT
    Transplant Proc; 2019 Oct; 51(8):2731-2734. PubMed ID: 31447189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use is associated with prolonged survival of renal transplant recipients.
    Wiesbauer F; Heinze G; Mitterbauer C; Harnoncourt F; Hörl WH; Oberbauer R
    J Am Soc Nephrol; 2008 Nov; 19(11):2211-8. PubMed ID: 18650477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin, Concomitant Prescription of Opioids, and Benzodiazepines among Kidney Transplant Recipients.
    Chen Y; Ahn JB; Bae S; Joseph C; Schnitzler M; Hess GP; Lentine KL; Lonze BE; Segev DL; McAdams-DeMarco M
    Clin J Am Soc Nephrol; 2023 Jan; 18(1):91-98. PubMed ID: 36719161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.